Compared to short-acting exenatide, long-acting ones such as dulaglutide, liraglutide, and exenatide once-weekly reduced hemoglobin A1c (HbA1c) by 0.51%, 0.45%, and 0.38% respectively [62]
Tap Click here to open the promo code box
doi: 10.1385/JMN:18:1-2:07 101 KesslerR
Read the Medication Guide provided by your pharmacist before your treatment starts
But as youll hear tonight, breakthroughs like these are anything but overnight. Chancellor Don Elliman Michael Holers, MD, Faculty Ventures director at CU Anschutz Innovations and Smyth Professor of Rheumatology, shared a story of his own research that illustrates how far back basic science can go and how CU Anschutz is helping move its scientists ideas forward faster
GLP-1 receptor (GLP-1R) agonists modulate enteric immune responses through the intestinal intraepithelial lymphocyte (IEL) GLP-1R